. Show Affiliations »
Abstract
Mesh: See more » Amsacrine/adverse effectsAmsacrine/chemistryAmsacrine/pharmacologyAmsacrine/therapeutic useAntineoplastic Agents/adverse effectsAntineoplastic Agents/chemistryAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useCarcinogens/adverse effectsCarcinogens/chemistryDisease Models, AnimalEtoposide/adverse effectsEtoposide/chemistryEtoposide/pharmacologyEtoposide/therapeutic useEvidence-Based MedicineHumansIntestinal AbsorptionMitoxantrone/adverse effectsMitoxantrone/chemistryMitoxantrone/pharmacologyMitoxantrone/therapeutic useNeoplasms/chemically inducedNeoplasms/epidemiologyNucleic Acid Synthesis Inhibitors/adverse effectsNucleic Acid Synthesis Inhibitors/chemistryNucleic Acid Synthesis Inhibitors/pharmacologyNucleic Acid Synthesis Inhibitors/therapeutic useResearch DesignRisk FactorsTeniposide/adverse effectsTeniposide/chemistryTeniposide/pharmacologyTeniposide/therapeutic useTissue DistributionTopoisomerase II Inhibitors
Substances: See more » Antineoplastic AgentsCarcinogensNucleic Acid Synthesis InhibitorsTopoisomerase II InhibitorsAmsacrineEtoposideTeniposideMitoxantrone
Year: 2000 PMID: 11000976 PMCID: PMC7196979
Source DB: PubMed Journal: IARC Monogr Eval Carcinog Risks Hum ISSN: 1017-1606